Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Author index

Page Path
HOME > Browse articles > Author index
Search
Li Zhou 1 Article
MicroRNA-373 Inhibits Cell Proliferation and Invasion via Targeting BRF2 in Human Non-small Cell Lung Cancer A549 Cell Line
Lei Wang, Junfeng Qu, Li Zhou, Fei Liao, Ju Wang
Cancer Res Treat. 2018;50(3):936-949.   Published online October 12, 2017
DOI: https://doi.org/10.4143/crt.2017.302
AbstractAbstract PDFPubReaderePub
Purpose
The purpose of this study was to investigate the biological role and mechanism of miR-373 targeting of TFIIB-related factor 2 (BRF2) in the regulation of non-small cell lung cancer (NSCLC) cells. Materials­and­Methods miRNA microarray chip analysis of four paired NSCLC and adjacent non-tumor tissues was performed. Quantitative real-time polymerase chain reaction (qRT-PCR) andwestern blotting were used to detect the expression levels of miR-373 and BRF2 in NSCLC tissues and cell lines. The dual-luciferase reporter method was performed to determine if BRF2 is a target of miR-373. MTT, wound-healing, Transwell, and flow cytometric assays were conducted to examine the proliferation, migration, invasion, and cell cycle progression of NSCLC A549 cells, respectively; western blotting was used to detect the expression of epithelial-mesenchymal transition (EMT)–related proteins.
Results
The miRNA microarray chip analysis demonstrated that miR-373 was down-regulated in NSCLC tissues, and this result was confirmed by qRT-PCR. Additionally, miR-373 was confirmed to target BRF2. Moreover, miR-373 expression was inversely correlated with BRF2 expression in NSCLC tissues and cell lines; both miR-373 down-regulation and BRF2 up-regulation were strongly associated with the clinicopathological features and prognosis of NSCLC patients. In vitro, overexpression of miR-373 markedly inhibited cell proliferation, migration, and invasion; up-regulated the expression of E-cadherin; and down-regulated the expression of N-cadherin and Snail in A549 cell. Knockdown BRF2 by siRNA resulted in effects similar to those caused by overexpression of miR-373.
Conclusion
MiR-373 is decreased in NSCLC, and overexpression of miR-373 can suppress cell EMT, and inhibit the proliferation, migration, and invasion of NSCLC A549 cells by targeting BRF2.

Citations

Citations to this article as recorded by  
  • MicroRNA‑373‑3p inhibits the proliferation and invasion of non‑small‑cell lung cancer cells by targeting the GAB2/PI3K/AKT pathway
    Xunxia Zhu, Xiaoyu Chen, Xuelin Zhang, Liting Zhao, Xiaoyong Shen
    Oncology Letters.2024;[Epub]     CrossRef
  • The role of EMG1 in lung adenocarcinoma progression: Implications for prognosis and immune cell infiltration
    Xingwei Wu, Zhenguo Wu, Zehang Xie, Haoyu Huang, Yingying Wang, Kun Lv, Hui Yang, Xiaocen Liu
    International Immunopharmacology.2024; 138: 112553.     CrossRef
  • The functions and molecular mechanisms of Tribbles homolog 3 (TRIB3) implicated in the pathophysiology of cancer
    Anam Arif, Ameer A. Alameri, Umer Bin Tariq, Shakeel Ahmed Ansari, Hader Ibrahim Sakr, Maytham T. Qasim, Fadhil F.M. Aljoborae, Andrés Alexis Ramírez-Coronel, Hijran Sanaan Jabbar, Gamal A. Gabr, Rasoul Mirzaei, Sajad Karampoor
    International Immunopharmacology.2023; 114: 109581.     CrossRef
  • Characteristics and Prognosis of 8p11.23-Amplified Squamous Lung Carcinomas
    Ioannis A. Voutsadakis
    Journal of Clinical Medicine.2023; 12(5): 1711.     CrossRef
  • MicroRNAs in cancer metastasis: biological and therapeutic implications
    Marie C. Sell, Charmaine A. Ramlogan-Steel, Jason C. Steel, Bijay P. Dhungel
    Expert Reviews in Molecular Medicine.2023;[Epub]     CrossRef
  • MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway
    Guang-Zhen Li, Guang-Xiao Meng, Guo-Qiang Pan, Xiao Zhang, Lun-Jie Yan, Rui-Zhe Li, Zi-Niu Ding, Si-Yu Tan, Dong-Xu Wang, Bao-wen Tian, Yu-Chuan Yan, Zhao-Ru Dong, Jian-Guo Hong, Tao Li
    Cancer Cell International.2023;[Epub]     CrossRef
  • Processing body (P-body) and its mediators in cancer
    Bernard Nsengimana, Faiz Ali Khan, Ebenezeri Erasto Ngowi, Xuefeng Zhou, Yu Jin, Yuting Jia, Wenqiang Wei, Shaoping Ji
    Molecular and Cellular Biochemistry.2022; 477(4): 1217.     CrossRef
  • MicroRNAs, Tristetraprolin Family Members and HuR: A Complex Interplay Controlling Cancer-Related Processes
    Cyril Sobolewski, Laurent Dubuquoy, Noémie Legrand
    Cancers.2022; 14(14): 3516.     CrossRef
  • Amplification of 8p11.23 in cancers and the role of amplicon genes
    Ioannis A. Voutsadakis
    Life Sciences.2021; 264: 118729.     CrossRef
  • MicroRNAs and Lung Cancer: A Review Focused on Targeted Genes
    Yao-Hui Wang, Zhi-Ruo Zhu, De Tong, Rui Zhou, Kui Xiao, Ling Peng
    Exploratory Research and Hypothesis in Medicine.2021; 000(000): 1.     CrossRef
  • MiR-373 Inhibits the Epithelial-Mesenchymal Transition of Prostatic Cancer via Targeting Runt-Related Transcription Factor 2
    Jianyi Pang, Limei Dai, Chen Zhang, Qinglei Zhang, Enas Abdulhay
    Journal of Healthcare Engineering.2021; 2021: 1.     CrossRef
  • miR-96-5p is the tumor suppressor in osteosarcoma via targeting SYK
    Taiping Wang, Yong Xu, Xin Liu, Yong Zeng, Lei Liu
    Biochemical and Biophysical Research Communications.2021; 572: 49.     CrossRef
  • MicroRNA as an Important Target for Anticancer Drug Development
    Zhiwen Fu, Liu Wang, Shijun Li, Fen Chen, Kathy Ka-Wai Au-Yeung, Chen Shi
    Frontiers in Pharmacology.2021;[Epub]     CrossRef
  • lncRNA SNHG16 promotes glioma tumorigenicity through miR-373/EGFR axis by activating PI3K/AKT pathway
    Xiang-Yang Zhou, Hong Liu, Zheng-Bin Ding, Hai-Peng Xi, Guang-Wei Wang
    Genomics.2020; 112(1): 1021.     CrossRef
  • Molecular characterization of lung cancer: A two‐miRNA prognostic signature based on cancer stem‐like cells related genes
    Yanping Cheng, Sheng Yang, Bo Shen, Yan Zhang, Xiaomei Zhang, Tong Liu, Siyi Xu, Jing Sui, Lihong Yin, Yuepu Pu, Geyu Liang
    Journal of Cellular Biochemistry.2020; 121(4): 2889.     CrossRef
  • miR-93, miR-373, and miR-17-5p Negatively Regulate the Expression of TBP2 in Lung Cancer
    Ye Li, Min Liang, Yunhui Zhang, Bing Yuan, Wenchao Gao, Zhizhou Shi, Jie Bai
    Frontiers in Oncology.2020;[Epub]     CrossRef
  • BRF2 as a promising indicator for radical lymph-node dissection surgery in patients with cN0 squamous cell carcinoma of the middle thoracic esophagus
    Yu Tian, Cong Wang, Ming Lu
    Surgery Today.2019; 49(2): 158.     CrossRef
  • Long noncoding RNA MNX1‐AS1 contributes to lung cancer progression through the miR‐527/BRF2 pathway
    Haibo Liu, Leng Han, Zhengjia Liu, Nan Gao
    Journal of Cellular Physiology.2019; 234(8): 13843.     CrossRef
  • MiRNA-195-5p Functions as a Tumor Suppressor and a Predictive of Poor Prognosis in Non-small Cell Lung Cancer by Directly Targeting CIAPIN1
    Jing Zheng, Tingting Xu, Feng Chen, Ying Zhang
    Pathology & Oncology Research.2019; 25(3): 1181.     CrossRef
  • Amyloid precursor protein and its phosphorylated form in non-small cell lung carcinoma
    Shigehiro Ito, Yasuhiro Miki, Ryoko Saito, Chihiro Inoue, Yoshinori Okada, Hironobu Sasano
    Pathology - Research and Practice.2019; 215(8): 152463.     CrossRef
  • An Inventive Report of Inducing Apoptosis in Non-Small Cell Lung Cancer (NSCLC) Cell Lines by Transfection of MiR-4301
    Abbas J. Avval, Ahmad Majd, Naghmeh Gholipour, Kambiz A. Noghabi, Anna Ohradanova-Repic, Ghasem Ahangari
    Anti-Cancer Agents in Medicinal Chemistry.2019; 19(13): 1609.     CrossRef
  • miR‑802 inhibits the aggressive behaviors of non‑small cell lung cancer cells by directly targeting FGFR1
    Jiexia Zhang, Jun Li, Shiyue Li, Chengzhi Zhou, Yinyin Qin, Xiaoxiang Li
    International Journal of Oncology.2019;[Epub]     CrossRef
  • Development and characterisation of a panel of phosphatidylinositide 3-kinase – mammalian target of rapamycin inhibitor resistant lung cancer cell lines
    Susan Heavey, Paul Dowling, Gillian Moore, Martin P. Barr, Niamh Kelly, Stephen G. Maher, Sinead Cuffe, Stephen P. Finn, Kenneth J. O’Byrne, Kathy Gately
    Scientific Reports.2018;[Epub]     CrossRef
  • 9,735 View
  • 350 Download
  • 25 Web of Science
  • 23 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP